procyclidine has been researched along with 1-phenyl-2-decanoylamino-3-morpholino-1-propanol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igarashi, Y; Inokuchi, JI; Jimbo, M; Kabayama, K; Nunomura, K; Yamagishi, K; Yamaki, T | 1 |
| Hara-Yokoyama, M; Inokuchi, JI; Ode, T | 1 |
2 other study(ies) available for procyclidine and 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
| Article | Year |
|---|---|
Development of a new inhibitor of glucosylceramide synthase.
Topics: Animals; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fibroblasts; Glucosyltransferases; Humans; Magnetic Resonance Spectroscopy; Morpholines; Procyclidine; Propanolamines; Pyrrolidines; Rats; Sphingolipids; Tumor Cells, Cultured | 2000 |
Pharmacological Modulation of Glycosphingolipid Metabolism.
Topics: Animals; Cell Line; Endosomes; Enzyme Inhibitors; Glucosyltransferases; Glycosphingolipids; Lysosomes; Mice; Morpholines; Procyclidine; Ras Homolog Enriched in Brain Protein; TOR Serine-Threonine Kinases | 2018 |